| Phaarmasia Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 523620 |
NSE Symbol : - |
P/E(TTM) : 25.27 |
|
ISIN Demat : INE486I01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.20 |
|
Book Value(₹) : 32.36 |
Market Cap(₹Cr) : 55.23 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 8.28 | 7.73 | 16.05 | 16.55 | 6.87 | 5.43 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 8.28 | 7.73 | 16.05 | 16.55 | 6.87 | 5.43 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.30 | 0.34 | 19.16 | 0.14 | 0.32 | 0.18 |
| Total Income | 8.58 | 8.08 | 35.21 | 16.69 | 7.19 | 5.61 |
| Total Expenditure | 8.24 | 8.40 | 15.21 | 14.94 | 6.78 | 6.05 |
| PBIDT | 0.35 | -0.32 | 19.99 | 1.75 | 0.40 | -0.43 |
| Interest | 0.01 | 0.18 | 0.02 | 0.00 | 0.03 | 0.00 |
| PBDT | 0.34 | -0.50 | 19.98 | 1.75 | 0.38 | -0.43 |
| Depreciation | 0.03 | 0.04 | 0.06 | 0.05 | 0.06 | 0.08 |
| Tax | 0.00 | 0.00 | 3.71 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.03 | 0.17 | -0.07 | -0.04 | 0.04 | 0.01 |
| Reported Profit After Tax | 0.34 | -0.70 | 16.27 | 1.74 | 0.27 | -0.53 |
| Extra-ordinary Items | 0.00 | 0.00 | 15.46 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.34 | -0.70 | 0.81 | 1.74 | 0.27 | -0.53 |
| EPS (Unit Curr.) | 0.50 | -1.03 | 23.84 | 2.54 | 0.40 | -0.77 |
| EPS (Adj) (Unit Curr.) | 0.50 | -1.03 | 23.84 | 2.54 | 0.40 | -0.77 |
| Calculated EPS (Unit Curr.) | 0.50 | -1.03 | 23.84 | 2.54 | 0.40 | -0.77 |
| Calculated EPS (Adj) (Unit Curr.) | 0.50 | -1.03 | 23.84 | 2.54 | 0.40 | -0.77 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.99 | -4.12 | 95.34 | 10.17 | 1.58 | -3.08 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.99 | -4.12 | 95.34 | 10.17 | 1.58 | -3.08 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 4.23 | -4.14 | 124.55 | 10.57 | 5.82 | -7.92 |
| PBDTM(%) | 4.11 | -6.47 | 124.49 | 10.57 | 5.53 | -7.92 |
| PATM(%) | 4.11 | -9.06 | 101.37 | 10.51 | 3.93 | -9.76 |
